504 related articles for article (PubMed ID: 12773629)
1. Interleukin-10 therapy--review of a new approach.
Asadullah K; Sterry W; Volk HD
Pharmacol Rev; 2003 Jun; 55(2):241-69. PubMed ID: 12773629
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.
Weiss E; Mamelak AJ; La Morgia S; Wang B; Feliciani C; Tulli A; Sauder DN
J Am Acad Dermatol; 2004 May; 50(5):657-75; quiz 676-8. PubMed ID: 15097948
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 does not affect IL-1-induced interleukin-6 and metalloproteinase production in human chondrosarcoma cells, SW1353.
Radons J; Falk W; Schubert TE
Int J Mol Med; 2006 Feb; 17(2):377-83. PubMed ID: 16391840
[TBL] [Abstract][Full Text] [Related]
7. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
8. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
9. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
[TBL] [Abstract][Full Text] [Related]
11. IL-21 in the pathogenesis and treatment of skin diseases.
Costanzo A; Chimenti MS; Botti E; Caruso R; Sarra M; Monteleone G
J Dermatol Sci; 2010 Nov; 60(2):61-6. PubMed ID: 20888735
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases.
McInnes IB; Gracie JA
Curr Opin Pharmacol; 2004 Aug; 4(4):392-7. PubMed ID: 15251134
[TBL] [Abstract][Full Text] [Related]
13. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
[TBL] [Abstract][Full Text] [Related]
14. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
[TBL] [Abstract][Full Text] [Related]
15. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
16. Is IL-1 a good therapeutic target in the treatment of arthritis?
Burger D; Dayer JM; Palmer G; Gabay C
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):879-96. PubMed ID: 16980212
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10: biology, role in inflammation and autoimmunity.
Lalani I; Bhol K; Ahmed AR
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):469-83. PubMed ID: 9433360
[TBL] [Abstract][Full Text] [Related]
18. Biology of IL-21 and the IL-21 receptor.
Mehta DS; Wurster AL; Grusby MJ
Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
[TBL] [Abstract][Full Text] [Related]
19. Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.
Rigopoulou EI; Abbott WG; Haigh P; Naoumov NV
Clin Immunol; 2005 Oct; 117(1):57-64. PubMed ID: 16006191
[TBL] [Abstract][Full Text] [Related]
20. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
